Aisel Health has raised €1.7m to expand its clinical and engineering team and support its entry into the UK market.
The Copenhagen-based health tech company is developing an operating system for psychiatry designed to reduce administrative work for clinicians by bringing together patient histories, interview recordings, existing documentation and patient accounts.
Founded in 2024 by Augusta Klingsten Peytz and Christian Houen, Aisel plans to use the funding to expand its clinical and engineering team.
The company is also pursuing a commercial pipeline of private psychiatry providers in the UK ahead of a planned seed funding round.
Aisel describes its technology as an operating system for psychiatry, organising information from different sources into structured, contextual insights before, during and after consultations.
The technology is intended to address a documentation challenge that has emerged as AI note-taking tools have become more common in psychiatric clinics.
Aisel argues that while these tools can cut the time spent producing notes, growing volumes of documentation can make relevant information harder for clinicians to find across patient records.
Company research called The Documentation Minute found that psychiatrists spent far longer gathering evidence from referrals, previous notes and multiple systems than writing notes themselves.
Augusta Klingsten Peytz, co-founder and chief executive of Aisel Health, said: “Psychiatry doesn’t need more generic technology bolted onto an already overburdened workflow.
“It needs a product built around the realities of psychiatric care – where clinicians bring judgment, empathy, and years of trained intuition, and the technology brings the speed, structure, and ability to hold together every detail about every patient, in a way no human memory can.”
Christian Houen, co-founder and chief product officer of Aisel Health, said: “AI scribes work – they write notes faster, and that’s great for immediate burnout.
“But that’s not what’s keeping waiting lists long. Make notes cheaper to produce, and you just make that information harder to find when a clinician needs it. We still have yet to overcome the human limitation of understanding everything that was ever written about every patient ever treated – that’s the problem we built Aisel to solve: giving clinicians exactly when and how they need it.”
The pre-seed round was led by Caesar Ventures, with participation from Nordic Web Ventures, LifeX and Angel Invest.
Existing backers Rockstart and EIFO also reinvested.
Carolin Gabor, managing partner and GP at Caesar Ventures, said: “Few problems in healthcare are as large or as overlooked as psychiatry’s, and few founders are as passionate about solving it the way Augusta and Christian are. We’re proud to lead this round, and look forward to supporting them to deliver the next generation of technology for psychiatry.”
